Literature DB >> 29690790

Neuroscience of Addiction: Relevance to Prevention and Treatment.

Nora D Volkow1, Maureen Boyle1.   

Abstract

Addiction, the most severe form of substance use disorder, is a chronic brain disorder molded by strong biosocial factors that has devastating consequences to individuals and to society. Our understanding of substance use disorder has advanced significantly over the last 3 decades in part due to major progress in genetics and neuroscience research and to the development of new technologies, including tools to interrogate molecular changes in specific neuronal populations in animal models of substance use disorder, as well as brain imaging devices to assess brain function and neurochemistry in humans. These advances have illuminated the neurobiological processes through which biological and sociocultural factors contribute to resilience against or vulnerability for drug use and addiction. The delineation of the neurocircuitry disrupted in addiction, which includes circuits that mediate reward and motivation, executive control, and emotional processing, has given us an understanding of the aberrant behaviors displayed by addicted individuals and has provided new targets for treatment. Most prominent are the disruptions of an individual's ability to prioritize behaviors that result in long-term benefit over those that provide short-term rewards and the increasing difficulty exerting control over these behaviors even when associated with catastrophic consequences. These advances in our understanding of brain development and of the role of genes and environment on brain structure and function have built a foundation on which to develop more effective tools to prevent and treat substance use disorder.

Entities:  

Keywords:  Clinical Drug Studies; Neurochemistry; Other Areas Of Neuroscience; Other Psychosocial Techniques/Treatments; Substance Use Disorder

Mesh:

Substances:

Year:  2018        PMID: 29690790     DOI: 10.1176/appi.ajp.2018.17101174

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  41 in total

1.  Targeting Youth to Prevent Later Substance Use Disorder: An Underutilized Response to the US Opioid Crisis.

Authors:  Wilson M Compton; Christopher M Jones; Grant T Baldwin; Frances M Harding; Carlos Blanco; Eric M Wargo
Journal:  Am J Public Health       Date:  2019-06       Impact factor: 9.308

2.  Deficient Functioning of Frontostriatal Circuits During the Resolution of Cognitive Conflict in Cannabis-Using Youth.

Authors:  Marilyn Cyr; Gregory Z Tau; Martine Fontaine; Frances R Levin; Rachel Marsh
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2018-10-31       Impact factor: 8.829

3.  Toward Precision Medicine for Smoking Cessation: Developing a Neuroimaging-Based Classification Algorithm to Identify Smokers at Higher Risk for Relapse.

Authors:  David W Frank; Paul M Cinciripini; Menton M Deweese; Maher Karam-Hage; George Kypriotakis; Caryn Lerman; Jason D Robinson; Rachel F Tyndale; Damon J Vidrine; Francesco Versace
Journal:  Nicotine Tob Res       Date:  2020-07-16       Impact factor: 4.244

Review 4.  Regulators of G Protein Signaling in Analgesia and Addiction.

Authors:  Farhana Sakloth; Claire Polizu; Feodora Bertherat; Venetia Zachariou
Journal:  Mol Pharmacol       Date:  2020-05-30       Impact factor: 4.436

Review 5.  Toward Addiction Prediction: An Overview of Cross-Validated Predictive Modeling Findings and Considerations for Future Neuroimaging Research.

Authors:  Sarah W Yip; Brian Kiluk; Dustin Scheinost
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2019-11-12

6.  Another silver lining?: Anthropological perspectives on the promise and practice of relaxed restrictions for telemedicine and medication-assisted treatment in the context of COVID-19.

Authors:  Emery Eaves; Robert Trotter; Julie Baldwin
Journal:  Hum Organ       Date:  2020-12-02

7.  Developmental Patterns of Gambling Participation and Substance use Throughout Adolescence in a Population Birth Cohort.

Authors:  Rene Carbonneau; Frank Vitaro; Mara Brendgen; Michel Boivin; Sylvana M Côté; Richard E Tremblay
Journal:  J Gambl Stud       Date:  2022-02-25

8.  Differences in small-world networks between methamphetamine and heroin use disorder patients and their relationship with psychiatric symptoms.

Authors:  Yan Liu; Qiang Li; Tianyi Zhang; Lei Wang; Yarong Wang; Jiajie Chen; Jia Zhu; Hong Shi; Wei Wang; Wei Li
Journal:  Brain Imaging Behav       Date:  2022-08-26       Impact factor: 3.224

Review 9.  Social vulnerabilities for substance use: Stressors, socially toxic environments, and discrimination and racism.

Authors:  Hortensia Amaro; Mariana Sanchez; Tara Bautista; Robynn Cox
Journal:  Neuropharmacology       Date:  2021-03-11       Impact factor: 5.250

Review 10.  Prenatal opioid exposure and vulnerability to future substance use disorders in offspring.

Authors:  Yaa Abu; Sabita Roy
Journal:  Exp Neurol       Date:  2021-01-29       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.